TABLE 3.
Unadjusted and Multivariate Logistic Regression Models to Assess the Relationship Between Achieving Durable Viral Suppression and the Intervention Among Adults With HIV Participating in CoRECT, Year 2016–2019, Pooled (N = 1893)
| Effect | Risk Ratio | 95% CI | |
|---|---|---|---|
| Unadjusted Risk Ratio by Site | |||
| Combined by site | 1.02 | 0.92 | 1.14 |
| Connecticut | 1.04 | 0.88 | 1.22 |
| Massachusetts | 0.92 | 0.76 | 1.10 |
| Philadelphia | 1.14 | 0.93 | 1.38 |
| Adjusted risk ratio | |||
| Intervention vs. Standard of Care | 0.98 | 0.88 | 1.09 |
| Connecticut vs. Philadelphia | 1.03 | 0.95 | 1.12 |
| Massachusetts vs. Philadelphia | 1.00 | 0.92 | 1.08 |
| Age (vs. 18–29 years) | |||
| 30–39 | 1.16 | 0.92 | 1.46 |
| 40–49 | 1.34 | 1.07 | 1.68 |
| 50–59 | 1.43 | 1.14 | 1.79 |
| 60 years or older | 1.58 | 1.24 | 2.02 |
| Race (vs. Non-Hispanic Black) | |||
| Hispanic/Latino | 1.00 | 0.86 | 1.16 |
| Non-Hispanic White | 1.10 | 0.95 | 1.27 |
| Other | 1.10 | 0.78 | 1.56 |
| Birth sex (vs. Male) | |||
| Female | 0.95 | 0.82 | 1.11 |
| Viral load suppression before randomization | |||
| Yes | 2.87 | 2.26 | 3.62 |
| CD4 count (vs. <50 cells/uL) | |||
| 51–199 | 1.08 | 0.91 | 1.28 |
| 200–349 | 1.30 | 1.09 | 1.54 |
| 350–499 | 1.13 | 0.92 | 1.39 |
| 500+ | 1.26 | 1.04 | 1.53 |
| Exposure category (vs. MSM, MSM/HET) * | |||
| IDU (IDU or HET/IDU) | 0.99 | 0.83 | 1.18 |
| MSM/IDU or MSM/HET/IDU | 1.08 | 0.90 | 1.29 |
| HET | 0.93 | 0.72 | 1.21 |
| Other | 1.07 | 0.878 | 1.30 |
*
HET = heterosexual; IDU = injection drug use; MSM = men who have sex with men; Other = perinatal, no identified risk, or not in record.